IQVIA Logo

Insight

Early Unwanted Immunogenicity Risk Assessment of Biotherapeutics

Home / Insights / Early Unwanted Immunogenicity Risk Assessment of Biotherapeutics

Chloe Ackaert presented this poster at PEGS – the Protein Engineering Summit – in May 2024, on behalf of Chloe Ackaert, Jana Schockaert, Aurelie Mazy, Ellen Boelen, Sofie Pattyn and Elise Pepermans.

 

Learn about T-cell proliferation assays to assess immunogenicity in immuno-oncology drug candidates.

 

Complete the form to view/download the poster.